Scott Cunningham

Trividia Health, Inc. develops, manufactures and markets diabetes monitoring and management products. It supplies blood glucose monitoring systems, cobranded under the TRUE name, to pharmacies, distributors and mail service providers. The company was founded by George H. Holley in 1985 and is headquartered in Fort Lauderdale, FL.

Part of Sinocare, Inc., Nipro Diagnostics (UK) Ltd. is a British medical company that offers the 4sure portfolio for people with type 1 diabetes. The company is based in Southampton, UK. The portfolio provides everything needed for frequent testing, insulin dosing calculation, and ?-ketone testing, without compromising on ease of use. The company was founded by Christopher J. Avery. Nipro Diagnostics (UK was acquired by Trividia Health, Inc., part of Sinocare, Inc. from January 07, 2016 on May 10, 2005 for $1.80 million.

Innova Biosciences Ltd. develops antibody labeling and bioconjugation kits. Its products include antibody/protein labeling, nanoparticles & conjugation kits, oligonucleotide conjugation, custom services, ELISA kits, streptavidin conjugates, protein A conjugates, antibody purification kits, ATPase & GTPase assay kits, maleimide-thiol products, immunogen kits and affinity resins. The firm offers custom services, testimonials, cost effectiveness, legal & privacy, quality management and product applications. The company was founded in 2002 and is headquartered in Cambridge, Canada.

Novarum Dx Ltd. is a British company that specializes in point of care testing with smartphones. Novarum Dx is based in Cardiff, UK. The private company is pioneers in reading lateral flow tests with a phone and offer a complete solution for reading, recording, and reporting test results without requiring AI or other mysterious black boxes.

Crucible Medtech Ltd. is a device development and consultancy firm that specializes in turning innovative ideas into high-impact products. The private company is based in Glasgow, UK. The British company collaborates with inventors, doctors, patients, buyers, and payers to identify the most promising innovations and turn them into viable products that positively impact users' lives. The company's team of experts works tirelessly to marry innovation with user requirements, regulatory compliance, and commercial viability. The company offers services such as design and development, research, regulatory compliance, and commercialization strategy. The company was founded in 2015 by John Wigham, Peter Estibeiro, Steve Howell. Peter Estibeiro has been the CEO since 2015.

Aureum Diagnostics Ltd. develops an electrochemical sensor and handheld low-cost instrument platform. The company is based in Glasgow, UK. The British company was founded in 2021 by Damion Corrigan. The CEO is Oliver Davies.